4//SEC Filing
WELCH JAMES H 4
Accession 0001209191-18-020443
CIK 0001305253other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 8:14 PM ET
Size
5.4 KB
Accession
0001209191-18-020443
Insider Transaction Report
Form 4
WELCH JAMES H
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2018-03-14+60,000→ 60,000 totalExercise: $9.50Exp: 2028-03-13→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from March 14, 2018 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001190278
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 8:14 PM ET
- Size
- 5.4 KB